MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
MARAVAI LIFESCIENCES HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.99+0.20 (+2.95%)
Close on Oct 19, 2026
- Market cap
- $1.03B
- P/E (TTM)
- –
- Dividend yield
- –
MARAVAI LIFESCIENCES HOLDINGS, INC. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 34.9%
- Operating margin
- -56.1%
- Net margin
- -37.1%
- Return on equity, FY2025
- -48.6%
Financial strength
- Current ratio
- 4.05
- Debt to equity
- 0.72
- Debt to assets
- 24.4%
- Cash to current liabilities
- 182.4%
Valuation
- P/E ratio
- –
- Price to sales
- 4.96
- Price to book
- 5.06
- Dividend yield
- –